I agree that this site is using cookies. You can find further informations here.
X
Bowlus, C.
170  results:
Search for persons X
?
1

EPH84 Administrative Claims-Based Algorithm to Identify Pat..:

Kowdley, K.V. ; Levy, C. ; Kachru, N....
Value in Health.  26 (2023)  6 - p. S179 , 2023
Link: https://doi.org/10.1016/..
 
?
2

EE59 Development and Validation of the Natural History Comp..:

Bowlus, C. ; Levy, C. ; Kowdley, K.V....
Value in Health.  26 (2023)  6 - p. S70 , 2023
Link: https://doi.org/10.1016/..
 
?
3

EPH110 Structured Literature Review of Evidence on the Clin..:

Levy, C. ; Bowlus, C. ; Kachru, N....
Value in Health.  26 (2023)  6 - p. S184 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Long-term efficacy and safety of obeticholic acid in patien..:

Bowlus, C.L. ; Trauner, M. ; Liberman, A....
Digestive and Liver Disease.  53 (2021)  - p. S18 , 2021
Link: https://doi.org/10.1016/..
 
?
5

OC.04.7 LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID I..:

Floreani, A. ; Bowlus, C.L. ; Trauner, M....
Digestive and Liver Disease.  53 (2021)  - p. S109 , 2021
Link: https://doi.org/10.1016/..
 
?
6

A43 LONG-TERM EFFICACY AND SAFETY OF OBETICHOCLIC ACID IN P..:

Hirschfield, G ; Jones, D ; Carbone, M...
Journal of the Canadian Association of Gastroenterology.  4 (2021)  Supplement_1 - p. 229-231 , 2021
Link: https://doi.org/10.1093/..
 
?
7

Durable response in the markers of cholestasis through 5 ye..:

Nevens, F. ; Shiffman, M.L. ; Drenth, J.P.H....
Digestive and Liver Disease.  52 (2020)  - p. e30 , 2020
Link: https://doi.org/10.1016/..
 
?
8

T06.01.3 DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THR..:

Nevens, F. ; Mitchell, S. ; Drenth, J.P....
Digestive and Liver Disease.  52 (2020)  - p. S158 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Three years of obeticholic Acid (OCA) therapy results in hi..:

Bowlus, C.L. ; Pockros, P.J. ; Kremer, A.E....
Digestive and Liver Disease.  51 (2019)  - p. e19 , 2019
Link: https://doi.org/10.1016/..
 
?
10

OC.01.4 THREE YEARS OF OBETICHOLIC ACID (OCA) THERAPY RESUL..:

Bowlus, C.L. ; Pockros, P. ; Kremer, A....
Digestive and Liver Disease.  51 (2019)  - p. e78 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Long-Term Obeticholic Acid (OCA) treatment associated with ..:

Bowlus, C. ; Pockros, P. ; Kremer, A.E....
Journal of Hepatology.  68 (2018)  - p. S111-S112 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Primary biliary cholangitis (PBC) in the U.S.: real world e..:

Bowlus, C. ; Carey, E. ; Demuth, G....
Journal of Hepatology.  68 (2018)  - p. S228-S229 , 2018
Link: https://doi.org/10.1016/..
 
?
13

PC.01.8 THE AESOP TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEB..:

Larusso, N.F. ; Bowlus, C.L. ; Levy, C....
Digestive and Liver Disease.  50 (2018)  2 - p. e67 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Pharmacokinetics and pharmacodynamics of seladelpar, a pote..:

Boudes, P. ; Michael, G. ; Bowlus, C....
Journal of Hepatology.  68 (2018)  - p. S235 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Treatment efficacy and safety of seladelpar, a selective pe..:

Hirschfield, G. ; Boudes, P. ; Bowlus, C....
Journal of Hepatology.  68 (2018)  - p. S105-S106 , 2018
Link: https://doi.org/10.1016/..
 
1-15